After Hours
$
27.82
Change
+0.14 +0.51%
Volume
Volume 34,541
Sep 29, 2023, 6:09 p.m.
Quotes are delayed by 20 min
Previous close
$ 28.24
$ 27.68
Change
-0.56 -1.98%
Day low
Day high
$27.60
$28.57

52 week low
52 week high
$17.47
$35.50

Market cap
$3.08B
Average volume
1.21M
P/E ratio
N/A
Rev. per Employee
$120,016
EPS
-3.14
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on RVMD
-
Revolution Medicines upgraded to overweight from neutral at J.P. Morgan
- Tomi Kilgore
-
Revolution Medicines started at outperform with $30 stock price target at Oppenheimer
- Tomi Kilgore
-
Revolution Medicines started at neutral with $24 stock price target at BofA Securities
- Tomi Kilgore
-
Revolution Medicines started at hold with $34 stock price target at Stifel Nicolaus
- Tomi Kilgore
-
Cancer Meeting Could Ignite These Biotech Stocks
- Barron's Online
-
The Pandemic Speeds Up the Health-Care Revolution
- Barron's Online
-
Cancer Meeting’s High Hopes for Amgen and Gilead
- Barron's Online
-
Why Blackstone Stock Looks Attractive
- Barron's Online
-
Revolution Medicines shares soar 85% in trading debut
- Ciara Linnane
-
Revolution Medicines prices IPO at $17 a share
- Jeremy C. Owens
-
Revolution Medicines increases size of planned IPO and raises price range
- Ciara Linnane
-
Revolution Medicines to offer 14 mln shares in planned IPO, priced at $16 to $17 each
- Ciara Linnane
Other News on RVMD
-
10-Q: REVOLUTION MEDICINES, INC.
- Edgar Online - (EDG = 10Q, 10K)
-
10-K: REVOLUTION MEDICINES, INC.
- Edgar Online - (EDG = 10Q, 10K)
-
Mass General Brigham, Inc Buys 2, Sells 3 in 4th Quarter
- GuruFocus.com
-
10-Q: REVOLUTION MEDICINES, INC.
- Edgar Online - (EDG = 10Q, 10K)
-
Top 5 2nd Quarter Trades of EcoR1 Capital, LLC
- GuruFocus.com
-
TRV GP IV, LLC Buys 3, Sells 2 in 2nd Quarter
- GuruFocus.com
Press Releases on RVMD
-
Circle Pharma Appoints Stephen Kelsey, MB ChB, MD, to its Board of Directors
- BusinessWire - BZX
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com